Abstract. Previously we reported that the hypoxia-inducible factor-1α (HIF-1α) expression correlated with cell proliferation and apoptosis under 500 mM of CoCl 2 treatment in a human gastric carcinoma cell line, MKN-1. Herein we report a similar correlation in other cell lines, MKN-45 and TMK-1. The dual-phase expression of HIF-1α was highest at 6 and 8 h of treatment in MKN-45 and TMK-1, respectively, while the peak in MKN-1 occurred at 4 h. The cell viability indices showed a similar dual phase to the HIF-1α expression, while the apoptotic indices started to increase as the level of the HIF-1α expression decreased. In our previous study, the FACS analysis showed a marked G 2 /M arrest and an increase of the pre-G 1 area in MKN-1 after 36 h of treatment, whereas the G 2 /M arrest was not observed in MKN-45 and TMK-1. The expression of cell cycle and apoptosis-related proteins showed a correlation with the HIF-1α expression and the FACS results, which suggested that the level of HIF-1α correlated with proliferation and apoptosis in human gastric carcinoma cell lines with a possible cell-type specific pattern.
Introduction
The hypoxia-inducible factor-1α (HIF-1α) is a transcription factor and major regulator of the adaptation of cancer cells to hypoxia (1) (2) (3) . Evidence suggests that HIF-1α is also a key player in carcinogenesis. Interest in the role of HIF-1α in cancer has increased remarkably over the last two decades, as this factor activates the transcription of many genes that code proteins involved in several pathways intimately related to cancer (3) (4) (5) . There is substantial clinical data associating the HIF-1α protein expression with poor outcomes in patients with a broad range of sporadic cancers, including adenocarcinoma of the breast, lung and colon and squamous cell tumors of the cervix, head and neck as well as malignancies of the central nervous system (CNS) (3, (6) (7) (8) (9) . Thus, the HIF-1α expression is common in cancer patients. In addition, the increased expression of HIF-1α correlates significantly with a poor response to chemotherapy and/or radiotherapy in esophageal (10) , oropharyngeal (11) and ovarian (7) cancer.
Only a few reports exist on the expression of HIF-1α in human gastric carcinomas. Zhong et al revealed that HIF-1α was immunohistochemically detected in cancer cells, but not in normal epithelial cells (6) . Urano et al indicated that the overexpression of HIF-1α correlated with p53 and the vascular endothelial growth factor (VEGF) protein expression immunohistochemically in a human gastric carcinoma (12) . According to Park et al, the expression of HIF-1α was dependent on a radical oxygen species in gastric cancer cells (13) . However, the biological significance of the HIF-1α expression has not been well elucidated in human gastric carcinoma cells (14) .
Our previous study revealed the expression of HIF-1α in the human gastric carcinoma cell line, MKN-1 (15) . The expression correlated with cell proliferation and apoptosis as shown by immunocytochemistry, cell viability assays, an apoptotic index, flow cytometry and Western blotting. In the present study, we examined the expression of HIF-1α and its correlation to cell proliferation in other human gastric carcinoma cell lines, namely, MKN-45 and TMK-1. Immunocytochemistry. Cells were seeded in 6-well plates on which glass coverslips were placed. Six or 36 hours after CoCl 2 treatment, the cells were fixed in 4% paraformaldehyde for 10 min at 4˚C.
Materials and methods

Cell
Immunocytochemistry was performed using the streptavidin-peroxidase complex (SAB) method with a Histofine SAB-PO (M) immunohistochemical staining kit (Nichirei, Tokyo, Japan). A mouse monoclonal antibody against HIF-1α (1:500, H1α67, Novus Biologicals, Littleton, CO) was used as the primary antibody. Immunoreactions were visualized with diaminobenzidine and the cells were counterstained with hematoxylin.
SDS PAGE and Western blotting. The SDS-PAGE and
Western blotting of the MKN-45 and TMK-1 proteins were performed as previously described (15) . The membrane was blotted with anti-HIF-1α monoclonal antibody (1:500, H1α67, Novus Biologicals), anti-P27/Kip1 monoclonal antibody (1:500, EA10; Oncogene, Cambridge, MA), anti-SKP2 monoclonal antibody (1:500, Zymed Laboratories Inc., San Francisco, CA), anti-Bcl-xL polyclonal antibody (1:500, Cell Signaling Tech), anti-Bax monoclonal antibody (1:500, Clone 4F11, MBL Co. Ltd., Nagoya Japan), anti-caspase-9 polyclonal antibody (1:500, Santa Cruz Biotechnology), anticleaved-caspase-9 polyclonal antibody (1:500, Cell Signaling, Beverly, MA) and anti-ß-actin monoclonal antibody (1:500, AC15; Sigma, St. Louis, MO).
FACS analysis. The cell cycle distribution was determined by a flow cytometric analysis of DNA content (Becton-Dickinson, San Jose, CA) at 0 h and after CoCl 2 treatment for 36 h. Cell suspensions were prepared by trypsinization and 1x10 6 cells/ml were washed twice with PBS(-). The cells were fixed overnight in 10 ml of 70% ethanol at 4˚C and incubated with RNase at a concentration of 0.25 mg/ml at 37˚C for 1 h. Then, the cells were treated with propidium iodide (50 μg/ml in PBS) and incubated for 30 min at 4˚C in the dark. Before their injection, the samples were passed through a 25-gauge needle to prevent cell clumping. DNA histograms were analyzed using lysis-II software (Becton-Dickinson) to evaluate the cell cycle components.
Results
CoCl 2 -induced HIF-1α expression. Treatment with CoCl 2 for 6 h induced the expression of HIF-1α in MKN-45 and TMK-1 cells in a dose-dependent manner up to a concentration of 500 mM (Fig. 1A) . Treatment with 500 μM CoCl 2 induced the HIF-1α expression in a time-dependent manner. The pattern of expression was dual phase, with a sharp increase followed by a gradual tapering until 36 h. The peak of expression was at 6 h in the MKN-45 cells and 8 h in the TMK-1 cells (Fig. 1B) .
Immunocytochemistry. Based on the protein expression of HIF-1α, immunocytochemistry was performed at 0, 6 and 36 h after the CoCl 2 treatment in the MKN-45 and TMK-1 cells (Fig. 2A) . In both cell lines, the HIF-1α-positive cells made up less than 10% of the untreated cells, in which immunoreactivity was observed mostly in the cytoplasm. On the other hand, the rates of the HIF-1α-positive cells were significantly increased in the treated cells after 6 h and were relatively low after 36 h in both MKN-45 and TMK-1. The viability index of the treated cells also showed a sharp increase until 6 h followed by a gradual tapering until 36 h, the relative value being 119.3 vs. 41.0% in MKN-45 and 131.4 vs. 11.1%, in TMK-1 (Fig. 2B) . This pattern correlated with the HIF-1α protein expression (Fig. 1B) and viability of the two cell lines under CoCl 2 treatment (Fig. 2B) . Notably, nuclear immunoreactivity was evident in the CoCl 2 -treated cells, but not in the untreated cells ( Fig. 2A) . was evident in the untreated cells (Fig. 3A) . No G 2 /M arrest was observed in either cell lines. These results suggested that the decrease in the expression of HIF-1α was correlated with the induction of apoptosis in the CoCl 2 -treated MKN-45 and TMK-1 cells.
As shown in Fig. 3B , the Western blot analysis revealed that the expression of SKP2 had a similar pattern to that of HIF-1α. On the other hand, the P27/Kip1 expression increased significantly after 36 h in the treated cells, which showed an inverse correlation with the alteration of the HIF-1α expression. The expression of these proteins was also suggested to correlate with the results of the FACS analysis 36 h after the treatment.
Apoptotic index and expression of apoptosis-related proteins.
Apoptosis was detected morphologically by Hoechst 33258 staining (Fig. 3C) . A significant number of apoptotic cells were observed among the CoCl 2 -treated MKN-45 and TMK-1 cells at 36 h compared to the untreated cells. The apoptotic indices also started to increase at 8 h until 36 h in the two cell lines in a time-dependent manner (Fig. 3D) . These patterns were relevant to those of the cell viability indices. Furthermore, it is reasonable to assume that the increase of the apoptotic index correlated with the decrease of the HIF-1α expression.
In both lines, Western blotting showed the expression of Bcl-2 and Bcl-xL, anti-apoptotic factors, in a similar pattern to that of HIF-1α. Moreover, the pro-apoptotic factors, Bax and cleaved-caspase-9, showed an increase in a time-dependent manner, coinciding with the decrease of the HIF-1α expression (Fig. 3E) . Overall, the patterns of Bcl-2, Bcl-xL, Bax and the cleaved-caspase-9 expression suggested a possible role for apoptosis in the correlation of the HIF-1α expression with MKN-45 and TMK-1 cell proliferation.
Discussion
Previously we reported a correlation between the CoCl 2 -induced HIF-1α expression and cell proliferation and apoptosis in the cell line, MKN-1 (15). The relationship was evidenced by immunocytochemistry, a cell viability and apoptotic index, FACS analysis and Western blotting. The data suggested that the expression level of HIF-1α regulates proliferation in human gastric carcinoma cells. This may also be the case in other human gastric carcinoma cell lines.
The present study detected the CoCl 2 -induced HIF-1α expression by Western blotting as well as immunocytochemistry in two human gastric carcinoma cell lines, MKN-45 and TMK-1. Notably, the pattern of expression was similar to that obtained in MKN-1 cells. A difference was noted when the expression peaked (MKN-1, 4 h vs. MKN-45 and TMK-1, 6 h), suggesting that it might be caused by a cell-type-specific property. Overall, the expression pattern of HIF-1α induced by CoCl 2 treatment was considered to be similar in all of the human gastric carcinoma cells examined in our studies. It is indicated that CoCl 2 treatment for a short time induced a transient up-regulation of the HIF-1α expression, but the level decreased with long-term exposure to CoCl 2 , which induced environment-mimicking hypoxic conditions. The decrease that followed the initial transient up-regulation suggested a negative-feedback mechanism on the prolonged exposure to hypoxia (17, 18) .
Moreover, cell viability in each cell line depended on the HIF-1α expression, i.e., down-regulation of the expression induced inhibition of cell growth due to apoptosis in human gastric carcinoma cells. An increase in the pre-G 1 fraction after 36 h of CoCl 2 treatment was also shown by an increase in the apoptotic indices of the MKN-45 and TMK-1 cells coinciding with the decrease of the HIF-1α expression. An up-regulation of the Bcl-xL expression occurred in the two cell types in correlation with the increase of the HIF-1α expression as well as a higher cell viability, while both cell types showed a down-regulation of Bcl-xL and an upregulation of Bax and cleaved-caspase-9 expression and an increase in the apoptotic index with the decrease of HIF-1α. These patterns were similar to that of the MKN-1 cells (15) , supporting the correlation between the HIF-1α expression and apoptosis suggested by other reports (19, 20) .
CoCl 2 -treated MKN-45 cells had a rather high viability index while the TMK-1 cells showed no significant difference after 36 h compared to the MKN-1 cells (15) . Previously, CoCl 2 -treated MKN-1 cells showed both a marked G 2 /M arrest and an increase in apoptotic areas after 36 h (15) . In the present study, neither the MKN-45 nor TMK-1 cells showed obvious cell cycle arrest after 36 h of treatment. This difference in results may be explained by the expression of SKP2 and P27/Kip1. The changes in the SKP2 and P27/Kip1 expression in the CoCl 2 -treated MKN-45 and TMK-1 cells were less prominent, whereas a drastic induction of P27/Kip1 expression was detected with the down-regulation of the HIF-1α expression in the CoCl 2 -treated MKN-1 cells (15) , suggesting that the lack of G 2 /M arrest in the CoCl 2 -treated MKN-45 and TMK-1 was due to an insufficient P27/Kip1 expression. Further studies are necessary to elucidate the relationship between the P27/Kip1 expression and HIF-1α.
Both the present and previous study (15) showed that a down-regulation of the HIF-1α expression of long-term exposure to CoCl 2 may suppress proliferation through apoptosis in human gastric carcinoma cells. The results indicate that HIF-1α may be a potential molecular target in the treatment of human gastric carcinoma, though further study is necessary to elucidate the mechanism(s) involved.
